Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.
about
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNRenal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.Review: Complement and its regulatory proteins in kidney diseases.Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complementIs the time ripe for kidney tissue proteomics?Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.Proteomic analysis of formalin-fixed paraffin-embedded glomeruli suggests depletion of glomerular filtration barrier proteins in two-kidney, one-clip hypertensive ratsCurrent concepts in C3 glomerulopathy.Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy.Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine.Dense deposit disease.Allelic variants of complement genes associated with dense deposit disease.IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometryClinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.Association of a novel complement factor H mutation with severe crescentic and necrotizing glomerulonephritis.C3 glomerulonephritis associated with monoclonal gammopathy: a case series.Treatment options for C3 glomerulopathyCauses of alternative pathway dysregulation in dense deposit disease.A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor HGlomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?Characterization of C3 in C3 glomerulopathy.Changing the concepts of immune-mediated glomerular diseases through proteomics.Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles.Kidney diseases caused by complement dysregulation: acquired, inherited, and still more to come.Annexin A2 Enhances Complement Activation by Inhibiting Factor HSoluble CR1 therapy improves complement regulation in C3 glomerulopathyThe incidence of possible causes of membranoproliferative glomerulonephritis: a single-center experienceDense deposit disease and C3 glomerulopathyGeneration of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathiesNovel biomarkers in glomerular disease.Dense deposit disease associated with monoclonal gammopathy of undetermined significance.American Society of Nephrology clinical pathological conference.Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.C3 glomerulopathy: a new classification.Neutrophils: game changers in glomerulonephritis?Idiopathic membranoproliferative glomerulonephritis: does it exist?Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.
P2860
Q26741542-805F4589-9314-40CC-864A-2B8805E08750Q31118069-1DB2F51D-F84F-451B-88F3-754F6A4D1D98Q33647738-721CECB4-BB1F-4F96-A620-ADB13DC42211Q33704832-5D40C491-3A24-458C-A953-F71C53F330ABQ33826145-9F537863-A929-46D3-A446-FA13AB4281B3Q33849695-49EAE64D-4A2F-4882-9D6D-3644E6B2E569Q33888480-41EF6EEC-E2CD-4663-A639-BCD99330B9E2Q34229134-2D187E57-BE34-4FA6-A0FF-0811B5DA5AFCQ34295006-6E5CAD03-F1D1-49C6-B401-4B0C86105205Q34555331-D3973B16-8F9B-4442-8DB4-5F4692DC53A8Q34574482-066D4B45-0655-41A2-97F3-FA639D240F54Q34587767-9EE49B49-B1E7-41FF-B5E3-CE9283E79721Q34691573-E22DEFC5-D295-48FA-B68D-35615A385DDAQ35124165-DE86B694-01A2-41FB-9F32-2E1DAFB5EFF4Q35142753-096178C1-C896-48EB-B58A-37412C311E9BQ35240658-BBCF6BD9-AED4-415F-9F84-443DEDA5B578Q35246525-8ADEB4BA-97CD-42C6-B068-9E3A5705933FQ35597061-F9B67EEB-02C3-4692-A3BA-527BBF236EE0Q35618793-490CDBB9-4F26-4093-8F83-2899CC088FE9Q35624672-8683B4C2-4BA0-4C56-92E3-91EA02F65CA8Q35758595-DBB8D8B1-F9DA-447D-B7E4-7E0C22C1F453Q35809292-2ED8C64F-CED5-4FEA-83F3-9CB2A96DA197Q35983428-F8BE6EA3-39C8-47D1-8090-1520356BEA49Q36099921-057A46AB-215D-4FE0-B584-2E74A3F3A44BQ36201993-BAE04DC5-84F2-4BA3-8088-9F371FBC44E1Q36323504-B365F5F0-7628-4644-B064-4D828A1A2CDCQ36438860-A86BC728-240E-4082-AF17-A2D20E104BCAQ36495141-6996A0E3-03F3-4132-9A5D-F50C9C127126Q37260204-8DC67D01-C09B-4B4B-8414-BF298BCA0D2BQ37275993-56A1F2F1-4689-4CD8-A0E6-096743060932Q37286653-9F10B903-14D7-4690-8E88-0EAE4BE84593Q37499843-3FEB9ADB-D79D-47E8-B0EC-9827CC7D3B86Q37658483-34AC813A-0FC9-41A3-A1D5-CB0AB5DBBD09Q37673264-39736C20-69B7-4472-879A-16719DC4D7FDQ37682273-DA85AA2B-B23D-422F-AD52-F1C63B4BC198Q37733586-29763DB8-94EC-410E-AB64-B36DAE9D922AQ37770399-595379F6-D90C-4755-AA86-B1EE7B6AB976Q37776362-89495415-D2D6-4608-B245-F5B7D862D738Q38026540-2D40A86E-C2A6-49D8-A2E3-089EF932F29EQ38048606-61045445-939D-43D9-95CD-10B13995FFCC
P2860
Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Glomeruli of Dense Deposit Dis ...... d terminal complement pathway.
@ast
Glomeruli of Dense Deposit Dis ...... d terminal complement pathway.
@en
type
label
Glomeruli of Dense Deposit Dis ...... d terminal complement pathway.
@ast
Glomeruli of Dense Deposit Dis ...... d terminal complement pathway.
@en
prefLabel
Glomeruli of Dense Deposit Dis ...... d terminal complement pathway.
@ast
Glomeruli of Dense Deposit Dis ...... d terminal complement pathway.
@en
P2093
P2860
P356
P1433
P1476
Glomeruli of Dense Deposit Dis ...... d terminal complement pathway.
@en
P2093
Ahmet Dogan
H Robert Bergen
Jason D Theis
Jeffrey D Gamez
Julie A Vrana
Richard J H Smith
Sanjeev Sethi
P2860
P2888
P304
P356
10.1038/KI.2008.657
P407
P577
2009-01-28T00:00:00Z
P5875
P6179
1047499230